Related Experiment Video

Updated: Jun 5, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

ERG oncogene modulates prostaglandin signaling in prostate cancer cells

Ahmed A Mohamed1, Shyh-Han Tan, Chen Sun

  • 1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of Health Sciences, Rockville, MD, USA.

Cancer Biology & Therapy
|December 24, 2010
PubMed

Insights

Prostate cancer cells with ERG gene fusions alter prostaglandin signaling. ERG protein directly impacts 15-hydroxy-prostaglandin dehydrogenase (HPGD) and prostaglandin E2 (PGE2) levels, influencing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Prostate cancer (CaP) often involves gene fusions, particularly the ETS related gene (ERG).
  • ERG's specific biological functions in prostate tumorigenesis are not fully understood.
  • Androgen-regulated gene fusions are common drivers in prostate cancer.

Purpose of the Study:

  • To investigate the role of ERG in prostaglandin signaling pathways in prostate cancer.
  • To elucidate the mechanism by which ERG influences prostaglandin metabolism and signaling.
  • To determine the impact of ERG on cancer cell growth and related gene expression.

Main Methods:

  • Utilized prostate cancer cell lines with TMPRSS2-ERG fusions.
  • Performed ERG knockdown experiments.
  • Assessed levels of 15-hydroxy-prostaglandin dehydrogenase (HPGD) and prostaglandin E2 (PGE2).
  • Investigated ERG protein binding to the HPGD promoter.
  • Analyzed effects on cell growth and urokinase-type plasminogen activator (uPA) expression.

Main Results:

  • ERG knockdown altered HPGD and PGE2 levels in prostate cancer cells.
  • ERG protein directly binds to the core promoter of the HPGD gene.
  • Prostaglandin E2-dependent cell growth and uPA expression were affected by ERG knockdown.
  • ERG appears to positively regulate prostaglandin-mediated signaling.

Conclusions:

  • ERG activation influences prostaglandin signaling in prostate cancer.
  • ERG's role in modulating HPGD and PGE2 suggests a mechanism for tumor progression.
  • Targeting ERG or prostaglandin pathways may offer therapeutic strategies for prostate cancer.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...